Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; none of the 31 sources its claims cite is checked for support yet.

High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options

Open access
Pond, M. J., Nori, A. V., Witney, A. A., Lopeman, R. C., Butcher, P. D., Sadiq, S. T. · 2014 · Clinical Infectious Diseases

Abstract

BACKGROUND: Empirical antibiotic therapy for nongonococcal urethritis (NGU) and cervicitis is aimed at Chlamydia trachomatis, but Mycoplasma genitalium, which also commonly causes undiagnosed NGU, necessitates treatment with macrolides or fluoroquinolones rather than doxycycline, the preferred chlamydia treatment. Prevalence of M. genitalium and associated genotypic markers of macrolide and fluoroquinolone resistance among men symptomatic of urethritis were investigated. Genetic diversity of M. genitalium populations was determined to infer whether findings were applicable beyond our setting. METHODS: Mycoplasma genitalium and other NGU pathogens were detected using nucleic acid amplification methods, and DNA sequencing was used to detect genotypic resistance markers of macrolide and fluoroquinolone antibiotics in 23S ribosomal RNA, gyrA, gyrB, and parC genes. MG191 single-nucleotide polymorphism typing and MG309 variable number tandem analysis were combined to assign a dual locus sequence type (DLST) to each positive sample. RESULTS: Among 217 men, M. genitalium prevalence was 16.7% (95% confidence interval [CI], 9.5%-24.0%) and C. trachomatis prevalence was 14.7% (95% CI, 7.8%-21.6%) in NGU cases. Nine of 22 (41%; 95% CI, 20%-62%) patients with M. genitalium were infected with DLSTs possessing genotypic macrolide resistance and 1 patient was infected with a DLST having genotypic fluoroquinolone resistance. Typing assigned M. genitalium DLSTs to 2 major clusters, broadly distributed among previously typed international strains. Genotypic macrolide resistance was spread within these 2 clusters. CONCLUSIONS: Mycoplasma genitalium is a frequent undiagnosed cause of NGU in this population with rates of macrolide resistance higher than those previously documented. Current guidelines for routine testing and empirical treatment of NGU should be modified to reduce treatment failure of NGU and the development of further resistance.

Overview

CoChat Summary

TL;DR

In this single-clinic observational study of 217 men with urethritis symptoms, *Mycoplasma genitalium* was detected in 16.7% of nongonococcal urethritis (NGU) cases, comparable to *Chlamydia trachomatis* (14.7%), and 41% of *M. genitalium* isolates had macrolide resistance markers. The authors conclude that routine *M. genitalium* testing and reappraisal of first-line NGU treatment are needed.

Key findings

  • Among 102 NGU cases, *M. genitalium* prevalence was 17/102 (16.7%; 95% CI, 9.5%–24.0%), similar to *C. trachomatis* at 15/102 (14.7%; 95% CI, 7.8%–21.6%; *P* = .86 for Ct vs Mg). In men with no urethritis, *M. genitalium* was 5/107 (4.7%) and *C. trachomatis* was 2/107 (1.9%).
  • Of 22 *M. genitalium*–positive samples, macrolide resistance markers were detected in 9 (41%; 95% CI, 20%–62%), and 1 sample (4.5%; 95% CI, 1%–21%) had a *parC* quinolone resistance–determining region mutation associated with fluoroquinolone resistance.
  • Macrolide resistance markers were carried in 6/17 NGU cases and 3/5 no-urethritis cases; the paper reports no obvious clinical associations with antibiotic resistance.
  • Typing showed 11/22 infections caused by 8 known MG191 sequence types and 11 novel types (A–J); phylogenetic analysis revealed two major clusters, both containing drug-resistant mutations (Major Cluster A: 7/12 resistant; Major Cluster B: 2/10 resistant).

Methods

  • Observational study of all men prospectively presenting with urethritis symptoms to the Genitourinary Medicine Clinic at St George’s Hospital, Tooting, London, between 28 September and 15 December 2011; 217 men were recruited, including 18 men who have sex with men.
  • Residual first-void urine samples were tested for *C. trachomatis* and *Neisseria gonorrhoeae* by NAAT and for *M. genitalium* and *Trichomonas vaginalis* by PCR; *M. genitalium*–positive extracts were tested for 23S rRNA macrolide resistance SNPs and *gyrA/gyrB/parC* QRDR SNPs, and typed by MG191 SNP and MG309 VNTR markers with phylogenetic analysis.
  • Prevalence was compared using χ² and McNemar tests; clinical notes were reviewed at 3 months after presentation to assess treatment failure.

Limitations

  • The paper states the study was limited by being based in a single clinic and conducted over a relatively short period; the authors addressed this by assessing *M. genitalium* genetic diversity with a dual-locus typing system.
  • Evident from the text: only 22 *M. genitalium*–positive samples were available, so resistance prevalence estimates have wide confidence intervals.
  • Evident from Table 2: many patients had no follow-up attendance, limiting assessment of treatment failure or persistence; the study also enrolled only men with urethritis symptoms, so findings may not directly generalize to women, cervicitis, or asymptomatic populations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/cid/cit752

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Phylogenetic tree of 18 of 22 dual locus sequence types of Mycoplasma genitalium detected from symptomatic men attending clinic. The tree was constructed only from samples in which both MgpB and MG309 sequences were available using the mgpB sequence type combined with MG309 vntr sequence (dual locus sequence type). Tips are colored by 23S rRNA single-nucleotide polymorphism type. Branch tips show identity number followed by the abbreviations ST, mgpB sequence type; vntr, MG309 sequence type repeat, and clinical syndrome; NGU, nongonococcal urethritis; Nil, no clinical syndrome. POS indicates positive control. The numbers along the branches represent bootstrap values. Major clusters A and B (see text).
Figure 1. Phylogenetic tree of 18 of 22 dual locus sequence types of Mycoplasma genitalium detected from symptomatic men attending clinic. The tree was constructed only from samples in which both MgpB and MG309 sequences were available using the mgpB sequence type combined with MG309 vntr sequence (dual locus sequence type). Tips are colored by 23S rRNA single-nucleotide polymorphism type. Branch tips show identity number followed by the abbreviations ST, mgpB sequence type; vntr, MG309 sequence type repeat, and clinical syndrome; NGU, nongonococcal urethritis; Nil, no clinical syndrome. POS indicates positive control. The numbers along the branches represent bootstrap values. Major clusters A and B (see text).CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 17 Not checked · 27 Own results and interpretations

12 more claims

Create a free account to see all 44 claims and to verify the 31 references still open.

See all claims — free account
  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 31 references

Research works printed but not linked: 3

  1. 2010, MMWR RECOMM REPORTS, 59, 1
  2. 2013, 4, e61481
  3. 2013, STIS, 89, A29

Cited by

Items 101–184 of 184

Metadata

Authors
Pond, M. J., Nori, A. V., Witney, A. A., Lopeman, R. C., Butcher, P. D., & Sadiq, S. T.
Affiliations
St George's, University of London (GB)
Corresponding author
Pond, M. J.
Venue
Clinical Infectious Diseases
Published
2013-11-26
Volume
58
Issue
5
Pages
631-637
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2167772364
Cited by
184
References
31
Citations by year
2026: 6 · 2025: 12 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 15 · 2020: 23 · 2019: 20 · 2018: 16 · 2017: 20 · 2016: 22 · 2015: 14 · 2014: 13
FWCI
10.51
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical Infectious Diseases (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Keywords
Mycoplasma genitalium, non-gonococcal urethritis, macrolide resistance, fluoroquinolone resistance, Chlamydia trachomatis, gyrA, gyrB, parC, 23S rRNA, empirical antibiotic therapy, men, prevalence, genetic diversity
MeSH terms
Anti-Bacterial Agents, DNA, Bacterial, DNA, Ribosomal, Humans, Male, Mycoplasma Infections, RNA, Ribosomal, 23S, Urethritis, Genetic Variation, Prevalence, Macrolides, Polymorphism, Single Nucleotide, Fluoroquinolones, Drug Resistance, Bacterial, DNA Gyrase, DNA Topoisomerase IV, Mycoplasma genitalium, Multilocus Sequence Typing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.